BioMarin Pharmaceutical
BMRN
#1907
Rank
NZ$17.75 B
Marketcap
NZ$92.44
Share price
-0.78%
Change (1 day)
-17.82%
Change (1 year)

BioMarin Pharmaceutical (BMRN) - Net assets

Net assets on the balance sheet as of September 2025 : NZ$10.48 Billion

According to BioMarin Pharmaceutical's latest financial reports the company has NZ$10.48 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

BioMarin Pharmaceutical - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$NZ$10.03 B28.13%
2023-12-31$NZ$7.82 B7.99%
2022-12-31$NZ$7.25 B16.09%
2021-12-31$NZ$6.24 B9.74%
2020-12-31$NZ$5.69 B22.74%
2019-12-31$NZ$4.63 B4.78%
2018-12-31$NZ$4.42 B11.88%
2017-12-31$NZ$3.95 B-0.97%
2016-12-31$NZ$3.99 B13.84%
2015-12-31$NZ$3.50 B79.89%
2014-12-31$NZ$1.95 B19.49%
2013-12-31$NZ$1.63 B32.16%
2012-12-31$NZ$1.23 B24.66%
2011-12-31$NZ$0.99 B6.54%
2010-12-31$NZ$0.92 B109.59%
2009-12-31$NZ$0.44 B-6.96%
2008-12-31$NZ$0.47 B94.54%
2007-12-31$NZ$0.24 B46.56%
2006-12-31$NZ$0.16 B-247.54%
2005-12-31$-NZ$0.12 Billion18.96%
2004-12-31$-NZ$95.27 Million-152.55%
2003-12-31$NZ$0.18 B-3.71%
2002-12-31$NZ$0.18 B-50.99%
2001-12-31$NZ$0.38 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Ultragenyx Pharmaceutical
RARE
NZ$27.97 M-99.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
NZ$10.8 M-99.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-NZ$0.79 Billion-107.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$149.38 B 1,324.82%๐Ÿ‡ซ๐Ÿ‡ท France
Amicus Therapeutics
FOLD
NZ$0.39 B-96.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
NZ$1.59 B-84.81%๐Ÿ‡บ๐Ÿ‡ธ USA